Precision medicine was the theme of the 2014 meeting of the European Society for Medical Oncology (ESMO), assembling 19,859 participants from nearly 134 countries worldwide.
A conference report by Professor Giuseppe Curigliano published in ecancermedicalscience covers the key abstracts of this outstanding meeting, summarising the most important research developments across the range of cancer modalities.
Cancer is a “spectrum” of diseases, and the precise application of personalised medicine must evolve to meet its challenges.
Emerging research on the characterisation of the immune system’s response to cancer has impacted studies across every type of cancer.
Read the conference report to learn more about the key developments of ESMO 2014.
We are an independent charity and are not backed by a large company or society. We raise every penny ourselves to improve the standards of cancer care through education. You can help us continue our work to address inequalities in cancer care by making a donation.
Any donation, however small, contributes directly towards the costs of creating and sharing free oncology education.
Together we can get better outcomes for patients by tackling global inequalities in access to the results of cancer research.
Thank you for your support.